Knight Therapeutics (TSE:GUD)

TSX:GUD

Canadian Market

GUD

Knight Therapeutics

RESEARCH TOOLSreports

Want to see TSE:GUD full AI Analyst Report?

Knight Therapeutics (GUD) Ownership - Who Owns Knight Therapeutics?

109 Followers

Knight Therapeutics (GUD) Ownership Overview

30.61% Insiders

3.74%

Mutual Funds

0.09% Other Institutional Investors

0.71% ETFs

64.85% Public Companies and

Individual Investors

The ownership structure of Knight Therapeutics (TSE:GUD) stock is a mix of institutional, retail, and individual investors. Approximately 4.54% of the company’s stock is owned by Institutional Investors, 30.61% is owned by Insiders, and 64.85% is owned by Public Companies and Individual Investors.

The ownership structure of Knight Therapeutics (TSE:GUD) stock is a mix of institutional, retail, and individual investors. Approximately 3.83% of the company’s stock is owned by Institutional Investors, 30.61% is owned by Insiders, and 0.71% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Apr 15, 2026	Michael Joseph Tremblay	xxxxxxxxxxxxx	C$151600
Mar 31, 2026	Santos Dias, Henrique José Dos	xxxxxxxxxxxxx	C$50247
Mar 31, 2026	Coelho Peev, Cristiane Zanqueta	xxxxxxxxxxxxx	C$35010
Dec 11, 2025	Jonathan Ross Goodman	xxxxxxxxxxxxx	C$18445

Show More Insider Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	21,794,446	Insider	22.23%	107,795,330
	7,535,300	Insider	7.69%	37,269,594
	1,486,271	Institution	1.52%	7,351,096
	1,345,051	Institution	1.37%	6,652,622
	534,840	Institution	0.55%	2,645,319
	525,529	Institution	0.54%	2,599,266
	350,252	Insider	0.36%	1,732,346
	246,614	Institution	0.25%	1,219,753
	178,678	Insider	0.18%	883,741
	82,817	Institution	0.08%	409,613

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value
	1,486,271	Institution	1.52%	7,351,096
	1,345,051	Institution	1.37%	6,652,622
	534,840	Institution	0.55%	2,645,319
	246,614	Institution	0.25%	1,219,753
	15,100	Institution	0.02%	74,685
	14,700	Institution	0.01%	72,706
	13,700	Institution	0.01%	67,760
	5,400	Institution	<0.01%	26,708
	2,400	Institution	<0.01%	11,870

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Dimensional International Small Cap Value ETF	284,122	Institution	0.29%	1,412,532
Dimensional International Small Cap ETF	126,616	Institution	0.13%	629,480
Dimensional International Core Equity 2 ETF	95,291	Institution	0.10%	473,746
SPDR S&P International Small Cap ETF	82,817	Institution	0.08%	411,731
IShare SP/TSX SmlCap	46,831	Institution	0.05%	300,187
1stAsst MornstrNBkQC	24,998	Institution	0.03%	145,738
Avantis International Equity ETF	20,346	Institution	0.02%	101,118
Dimensional International Core Equity Market ETF	16,000	Institution	0.02%	79,545
iShr MSCIMultfactrCA	6,832	Institution	<0.01%	31,427
Dimensional International Vector Equity ETF	200	Institution	<0.01%	994

FAQ

Who Owns Knight Therapeutics (TSE:GUD)?

According to the latest TipRanks data, approximately 0.09% of the company's stock is held by institutional investors, 30.61% is held by insiders, and 64.85% is held by retail investors.

What percentage of Knight Therapeutics (TSE:GUD) stock is held by institutional investors?

According to the latest TipRanks data, approximately 0.09% of Knight Therapeutics (TSE:GUD) stock is held by institutional investors.

What percentage of Knight Therapeutics (TSE:GUD) stock is held by retail investors?

According to the latest TipRanks data, approximately 64.85% of Knight Therapeutics (TSE:GUD) stock is held by retail investors.

Who owns the most shares of Knight Therapeutics (TSE:GUD)?

Jonathan Ross Goodman owns the most shares of Knight Therapeutics (TSE:GUD).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.